Reducing Distress from Auditory Verbal Hallucinations: A Multicenter, Parallel, Single-Blind, Randomized Controlled Feasibility Trial of Relating Therapy
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Introduction: There is a significant demand for interventions that reduce distress related to auditory verbal hallucinations (AVHs). AVH distress is associated with the way voice hearers relate with AVHs. We aimed to establish the feasibility of a randomized controlled trial to demonstrate that adding “Relating Therapy” (RT) to treatment as usual (TAU) is superior to TAU in reducing AVH distress. Methods: We conducted a multicenter, parallel, single-blind, randomized controlled feasibility trial in five mental health centers in Germany. Participants were ≥19 years of age, had persistent and distressing AVHs, and had a diagnosis of a schizophrenia-spectrum disorder. RT was delivered over a maximum of 16 sessions within 5 months. Blind assessments were conducted at baseline and at 5 and 9 months. Feasibility outcomes were the number of patients recruited and retained, and safety and therapist adherence. The primary endpoint was the distress factor score of the AVH subscale of the Psychotic Symptoms Rating Scales at 9 months. Results: Eighty-five of 177 enrolled participants were randomized into RT + TAU (n = 43) or TAU (n = 42). Feasibility was excellent with 87% retention at 9 months, 86% reaching treatment uptake criteria, 98% therapist adherence, and no unexpected serious adverse reactions. Compared to TAU, RT + TAU showed nonsignificant trends toward less AVH distress (b = −2.40, SE = 1.52, p = 0.121, 90% CI (−4.94 to 0.15) and stronger improvement on all but one of the secondary outcomes. Conclusion: A randomized controlled trial of RT is feasible, safe, and well accepted. Our results provide an encouraging basis to further test the efficacy of RT in a definitive multicenter trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“only two studies reported using all six blinding methods identified in the content analysis [52, 69].”
From Blinding outcome assessors in randomised controlled trials of psychological interventions: how is it done? A narrative review (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies that provided extensive detail about all blinding methods strengthen confidence in the validity of findings [52, 69].”
From Blinding outcome assessors in randomised controlled trials of psychological interventions: how is it done? A narrative review (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An excellent example by Lincoln and colleagues provided an in-depth description which spanned across all six categories of blinding methods identified in the content analysis [52].”
From Blinding outcome assessors in randomised controlled trials of psychological interventions: how is it done? A narrative review (2026) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Löwe, B., Kroenke, K., Herzog, W., & Gräfe, K. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00198-8 · Cited by 1,558 · cited 1×
“…Life Scale (EQ-5D-5L) [24], negative relating to voices and social others measured with the Voice and You questionnaire (VAY) [12] and the AP-PROVE questionnaires [14], depressive symptoms (PHQ-9) [25], AVH-Frequency (PSYRATS-Frequency) [19, 20] and number of rehospitalizations, each at T1 and T2.”
HADDOCK, G., McCARRON, J., TARRIER, N., & FARAGHER, E. B. (1999) · Psychological Medicine · doi:10.1017/s0033291799008661 · Cited by 1,461 · cited 3×
“AVHdistress, measured by the AVH subscale of the Psy-chotic Symptoms Rating Scale (PSYRATS-AVH) [19, 20] at 9 months (T2), was chosen as the primary preliminary clinical outcome to estimate the effect size that can be expected from RT in the German health care system.”
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931 · cited 1×
“Although AVHs generally respond well to pharmacological therapy [5], their positive short-term effects need to be balanced against their disadvantages such as serious side effects [33], in particular when used long-term [6, 34] and the high risk of relapse if discontinued [35].”
The statistical interpretation of pilot trials: should significance thresholds be reconsidered?
Lee, E. C., Whitehead, A. L., Jacques, R. M., & Julious, S. A. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-41 · Cited by 423
Craig, T. K., Rus-Calafell, M., Ward, T., Leff, J. P., Huckvale, M., Howarth, E., Emsley, R., & Garety, P. A. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30427-3 · Cited by 403
Auditory Verbal Hallucinations in Persons With and Without a Need for Care
Johns, L. C., Kompus, K., Connell, M., Humpston, C., Lincoln, T. M., Longden, E., Preti, A., Alderson-Day, B., Badcock, J. C., Cella, M., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu005 · Cited by 311
Self-citationvan der Gaag, M., Valmaggia, L. R., & Smit, F. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.016 · Cited by 271 · cited 1×
“Meta-analyses con fi rm an effect of cognitive behavior therapy for psychosis on AVH as a secondary outcome [7, 8].”
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.182683 · Cited by 244 · cited 2×
“Also, long-term medication is not accepted by all patients and bears the risk of adverse effects [6].”
Methodological Recommendations for Trials of Psychological Interventions
Guidi, J., Brakemeier, E.-L., Bockting, C. L. H., Cosci, F., Cuijpers, P., Jarrett, R. B., Linden, M., Marks, I., Peretti, C. S., Rafanelli, C., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000490574 · Cited by 205 · cited 1×
“All procedures and reporting follow the Methodological Recommendations for Trials of Psychological Interventions [17].”
Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders
McCarthy-Jones, S., Smailes, D., Corvin, A., Gill, M., Morris, D. W., Dinan, T. G., Murphy, K. C., Anthony O′Neill, F., Waddington, J. L., Bank, A. S. R., et al. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.102 · Cited by 152
Birchwood, M., Michail, M., Meaden, A., Tarrier, N., Lewis, S., Wykes, T., Davies, L., Dunn, G., & Peters, E. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70247-0 · Cited by 146
Haddock, G., Devane, S., Bradshaw, T., McGovern, J., Tarrier, N., Kinderman, P., Baguley, I., Lancashire, S., & Harris, N. (2001) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465801002089 · Cited by 143 · cited 1×
“Two randomly selected recordings per participant were rated for adherence by MH and RM using an adapted version of the Cognitive Therapy Scale for Psychosis (CTS-Psy [21]), in which the original items F, G, and H were changed to re fl ect RT.”
Relating Therapy for distressing auditory hallucinations: A pilot randomized controlled trial
Hayward, M., Jones, A.-M., Bogen-Johnston, L., Thomas, N., & Strauss, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.019 · Cited by 128 · cited 6×
“RT for AVH is a symptom-speci fi c behaviorally oriented intervention that targets interpersonal relating as a key mechanism associated with AVH distress [16].”
InfluentialSelf-citationIs Chronicity a Function of the Relationship Between the Person and the Auditory Hallucination?
Benjamin, L. S. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.2.291 · Cited by 123 · cited 1×
“One likely mechanism stems from the relationship people form with their AVH [11].”
Symptom Dimensions of the Psychotic Symptom Rating Scales in Psychosis: A Multisite Study
Woodward, T. S., Jung, K., Hwang, H., Yin, J., Taylor, L., Menon, M., Peters, E., Kuipers, E., Waters, F., Lecomte, T., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu014 · Cited by 116 · cited 3×
“AVHdistress, measured by the AVH subscale of the Psy-chotic Symptoms Rating Scale (PSYRATS-AVH) [19, 20] at 9 months (T2), was chosen as the primary preliminary clinical outcome to estimate the effect size that can be expected from RT in the German health care system.”
Kjelby, E., Sinkeviciute, I., Gjestad, R., Kroken, R. A., Løberg, E.-M., Jørgensen, H. A., Hugdahl, K., & Johnsen, E. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.07.003 · Cited by 106
Sorrell, E., Hayward, M., & Meddings, S. (2010) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465809990506 · Cited by 85 · cited 2×
“Notably, these relating styles have been found to discriminate between clinical and nonclinical voice hearers [13], which suggests that the relating style re fl ects a relevant patho-mechanism in the formation and maintenance of voice-related distress.”
Self-citationA validation of a new measure of activity in psychosis
JOLLEY, S., GARETY, P., ELLETT, L., KUIPERS, E., FREEMAN, D., BEBBINGTON, P., FOWLER, D., & DUNN, G. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.012 · Cited by 78 · cited 1×
“…outcomes were: the AVH distress (PSYRATS-AVH) at T1, the time spent in goal-directed activities measured with the Time Budget Measure (TBM) [23], health related quality of life measured with the EuroQuol Quality of Life Scale (EQ-5D-5L) [24], negative relating to voices and social others…”
The voice and you: development and psychometric evaluation of a measure of relationships with voices
Hayward, M., Denney, J., Vaughan, S., & Fowler, D. (2008) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.561 · Cited by 68 · cited 2×
“Previous research indicates that patients often have subordinating and intrusive relationships with their AVH, which bear similarities to the relationships with people within their social environments [12, 13].”
Self-citationChow, R. T. S., Whiting, D., Favril, L., Ostinelli, E. G., Cipriani, A., & Fazel, S. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105454 · Cited by 66 · cited 1×
“Although AVHs generally respond well to pharmacological therapy [5], their positive short-term effects need to be balanced against their disadvantages such as serious side effects [33], in particular when used long-term [6, 34] and the high risk of relapse if discontinued [35].”
Investigational and Therapeutic Applications of Transcranial Magnetic Stimulation in Schizophrenia
Mehta, U. M., Naik, S. S., Thanki, M. V., & Thirthalli, J. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1076-2 · Cited by 65 · cited 1×
“Although severe adverse effects (i.e., seizures) are rare, the mean observed effects on AVH are also only small to moderate and their durability is short-lasting (4 – 6 weeks) [32].”
Cuijpers, P., Quero, S., Papola, D., Cristea, I. A., & Karyotaki, E. (2021) · Psychological Medicine · doi:10.1017/s0033291719003581 · Cited by 62 · cited 1×
“Differences in TAU effects be-tween different countries have also been observed in other psychological intervention studies [31] and are likely due to differences in the quality of standard care between countries.”
Young, H. M. L., Goodliffe, S., Madhani, M., Phelps, K., Regen, E., Locke, A., Burton, J. O., Singh, S., Smith, A., & Conroy, S. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193756 · Cited by 59 · cited 1×
“The progression criterion for treatment exposure, retention, and data collection for a future trial was set in accordance with the recommendations for psychological RCTs to a rate of at least 80% [29].”
Dellazizzo, L., du Sert, O. P., Phraxayavong, K., Potvin, S., O’Connor, K. P., & Dumais, A. (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2322 · Cited by 46 · cited 1×
“Different types of negative relating to AVH, such as passive and distant or aggressive relating, have been shown to be associated with increased AVH distress in correlational [14] and qualitative studies of dialogues with voices within therapy [15].”
Hayward, M., Schlier, B., Strauss, C., Rammou, A., & Lincoln, T. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.003 · Cited by 26 · cited 2×
“…Life Scale (EQ-5D-5L) [24], negative relating to voices and social others measured with the Voice and You questionnaire (VAY) [12] and the AP-PROVE questionnaires [14], depressive symptoms (PHQ-9) [25], AVH-Frequency (PSYRATS-Frequency) [19, 20] and number of rehospitalizations, each at T1 and T2.”
Self-citationIddrisu, A., & Gumedze, F. N. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0639-y · Cited by 21 · cited 1×
“Sensitivity analyses were conducted: (1) after multiple imputation using “ jump to reference ” to assess non-random patterns of missing data [30], (2) using “ complete cases ” only, (3) in the per-protocol-population (i.e., received ≥ 8 sessions RT and CTS-Psy-adapted ≥ 30), with missing data…”
Johnsen, E., Sinkeviciute, I., Løberg, E., Kroken, R. A., Hugdahl, K., & Jørgensen, H. A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-241 · Cited by 20 · cited 2×
“AVH in the context of psychotic disorders are generally treated with antipsychotic medication, but not all patients bene fi t [5].”
The psychological therapy preferences of patients who hear voices
Berry, C., Baloc, A.-I., Fowler, D. G., Bibby-Jones, A.-M., Hazell, C. M., & Hayward, M. (2022) · Psychosis · doi:10.1080/17522439.2022.2095000 · Cited by 17
Self-citationSchlier, B., Buck, L., Müller, R., Lincoln, T. M., Bott, A., & Pillny, M. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102291 · Cited by 14
Self-citationEffect sizes for contrasts of estimated marginal effects
Shaw, B. P. (2022) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x221083901 · Cited by 12 · cited 2×
“…that in pilot trials, signi fi cance levels other than the traditional 5% should be considered to provide preliminary evidence for ef fi cacy and that con fi dence intervals, rather than signi fi cance tests, should be the focus to provide an estimated range of possible treatment effects [27, 28].”
InfluentialLincoln, T. M., Pillny, M., Schlier, B., & Hayward, M. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046390 · Cited by 10 · cited 1×
“People with lived experience of AVH (i.e., the Empower Peers to Research Network in Hamburg, and the Psychosis Lived Experience Group in the UK) were consulted on the selection of outcomes (see [26]).”
Self-citation
Cited by
Christensen, M. J., Rydborg, M. P., Jørgensen, R., Nielsen, C. D., Mainz, J., Bell, I., Thomas, N., Smith, L. C., Mariegaard, L. S., Ward, T., et al. (2025) · JMIR Serious Games · doi:10.2196/77920 · Cited by 12
Thomas, N., Ward, T., Longden, E., Bell, I., Brand, R. M., Christensen, M. J., Glenthøj, L. B., Rus‐Calafell, M., & Hayward, M. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf142 · Cited by 14
“11 , 38-41 ,55 To the best of our knowledge, the first labelling of a therapy for hearing voices as overtly “relational” was an early case series of relating therapy (RT).”
InfluentialSelf-citationWard, T., Ball, H., Montague, A. E., Xanidis, N., Myrie, C. V., Murcutt, I., Oshodi, E., Edwards, C., Hardy, A., Clancy, M., et al. (2025) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.70027 · Cited by 4
Relating Therapy for distressing voices: A treatment protocol
Hayward, M., Pillny, M., & Lincoln, T. M. (2025) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12595 · Cited by 4
Self-citationKokubun, K., Nemoto, K., & Yamakawa, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15060617 · Cited by 4
“This decision has been supported by previous research [72] and therefore many recent pilot studies have also adopted a p -value of 0.1 for statistical significance, e.g., [73–75].”
Influential
Metadata
- Authors
- Lincoln, T. M., Schlier, B., Müller, R., Hayward, M., Fladung, A.-K., Bergmann, N., Böge, K., Gallinat, J., Mahlke, C., Gonther, U., Lang, T., Exner, C., Buchholz, A., Stahlmann, K., Zapf, A., Rauch, G., & Pillny, M.
- Affiliations
- Universität Hamburg (DE)
- University of Sussex (GB)
- Charité – Universitätsmedizin Berlin (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Leipzig University (DE)
- Humboldt-Universität zu Berlin (DE)
- Corresponding author
- Pillny, Matthias
- ORCID
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2024-08-21
- Volume
- 93
- Issue
- 5
- Pages
- 328-339
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- PMC
- PMC11469652
- OpenAlex
- W4401794416
- Cited by
- 18
- References
- 28
- Citations by year
- 2026: 6 · 2025: 12
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (LI 1298/9-1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- auditory verbal hallucinations, voice hearing, psychosis, schizophrenia spectrum disorders, usual care, feasibility, therapist adherence, patient retention
- MeSH terms
- Psychological Distress, Adult, Feasibility Studies, Female, Germany, Hallucinations, Humans, Male, Middle Aged, Schizophrenia, Stress, Psychological, Single-Blind Method, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

